Omega-3 as well as caloric restriction prevent the age-related modifications of cholesterol metabolism

Mechanisms of Ageing and Development

Volumn 129, Issue 12, 2008, Pages 722-727

  Martini, Chiara ^a   Pallottini, Valentina ^a   De Marinis, Elisabetta ^a   Marino, Maria ^a   Cavallini, Gabriella ^b   Donati, Alessio ^b   Straniero, Sara ^b   Trentalance, Anna ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Ageing; Caloric restriction; HMG CoAR; Hypercholesterolemia; Omega 3

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; OMEGA 3 FATTY ACID; REACTIVE OXYGEN METABOLITE;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; CALORIC RESTRICTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DIET SUPPLEMENTATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FISCHER 344 RAT; HYPERCHOLESTEROLEMIA; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALORIC RESTRICTION; CHOLESTEROL; FATTY ACIDS, OMEGA-3; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERCHOLESTEROLEMIA; LIVER; MALE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, LDL;

RATTUS;

EID: 56949088237     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2008.09.010     Document Type: Article

References (36)

1. Boak L., and Chin-Dusting J.P. Hypercholesterolemia and endothelium dysfunction: role of dietary supplementation as vascular protective agents. Curr. Vasc. Pharmacol. 2 (2004) 45-52
2. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. Nutr. Health Aging 8 (2004) 163-174
3. Brown M.S., and Goldstein J.L. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 21 (1980) 505-517
4. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
5. Bruscalupi G., Leoni S., Mangiantini M.T., Minieri M., Spagnuolo S., and Trentalance A. True uncoupling between cholesterol synthesis and 3-hydroxy-3-methylglutaryl coenzyme A reductase in an early stage of liver regeneration. Cell. Mol. Biol. 31 (1985) 365-368
6. Dirks A.J., and Jones K.M. Statin-induced apoptosis and skeletal myopathy. Am. J. Physiol. Cell Physiol. 291 (2006) C1208-C1212
7. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., Langendorfer A., Stein E.A., Kruyer W., and Gotto Jr. A.M. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279 (1998) 1615-1622
8. Espenshade P.J., and Hughes A.L. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41 (2007) 401-427
9. Gaussin V., Skarlas P., Ching Y.P., Hardie D.G., and Hue L. Distinct type-2A protein phosphatases activate HMGCoA reductase and acetyl-CoA carboxylase in liver. FEBS Lett. 413 (1997) 115-118
10. Geelen M.J., Gibson D.M., and Rodwell V.W. Hydroxymethylglutaryl-CoA reductase-the rate-limiting enzyme of cholesterol biosynthesis. A report of a meeting held at Nijenrode Castle, Breukelen, The Netherlands, August 24, 1985. FEBS Lett. 201 (1986) 183-186
11. Gent J., and Braakman I. Low-density lipoprotein receptor structure and folding. Cell. Mol. Life Sci. 61 (2004) 2461-2470
12. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
13. Hardie D.G. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim. Biophys. Acta 1123 (1992) 231-238
14. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
15. Holub D.J., and Holub B.J. Omega-3 fatty acids from fish oils and cardiovascular disease. Mol. Cell. Biochem. 263 (2004) 217-225
16. Istvan E.S., Palnitkar M., Buchanan S.K., and Deisenhofer J. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis. EMBO J. 19 (2000) 819-830
17. LaRosa J.C., Hunninghake D., Bush D., Criqui M.H., Getz G.S., Gotto Jr. A.M., Grundy S.M., Rakita L., Robertson R.M., Weisfeldt M.L., et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. Circulation 81 (1990) 1721-1733
18. Liu Q., and Hofmann P.A. Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 286 (2004) H2204-2212
19. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
20. Marino M., Pallottini V., D'Eramo C., Cavallini G., Bergamini E., and Trentalance A. Age-related changes of cholesterol and dolichol biosynthesis in rat liver. Mech. Ageing Dev. 123 (2002) 1183-1189
21. Martini C., and Pallottini V. Cholesterol: from feeding to gene regulation. Genes Nutr. 2 (2007) 181-193
22. Martini C., Pallottini V., Cavallini G., Donati A., Bergamini E., and Trentalance A. Caloric restrictions affect some factors involved in age-related hypercholesterolemia. J. Cell. Biochem. 101 (2007) 235-243
23. Masoro E.J. Overview of caloric restriction and ageing. Mech. Ageing Dev. 126 (2005) 913-922
24. Matsuzaki M., Kita T., Mabuchi H., Matsuzawa Y., Nakaya N., Oikawa S., Saito Y., Sasaki J., Shimamoto K., and Itakura H. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ. J. 66 (2002) 1087-1095
25. Pallottini V., Martini C., Pascolini A., Cavallini G., Gori Z., Bergamini E., Incerpi S., and Trentalance A. 3-Hydroxy-3-methylglutaryl coenzyme A reductase deregulation and age-related hypercholesterolemia: a new role for ROS. Mech. Ageing Dev. 126 (2005) 845-851
26. Pallottini V., Martini C., Bassi A.M., Romano P., Nanni G., and Trentalance A. Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J. Hepatol. 44 (2006) 368-374
27. Pallottini V., Martini C., Cavallini G., Donati A., Bergamini E., Notarnicola M., Caruso M.G., and Trentalance A. Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia. J. Cell. Biochem. 98 (2006) 1044-1053
28. Pallottini V., Martini C., Cavallini G., Bergamini E., Mustard K.J., Hardie D.G., and Trentalance A. Age-related HMG-CoA reductase deregulation depends on ROS-induced p38 activation. Mech. Ageing Dev. 128 (2007) 688-695
29. Reynolds G.A., Basu S.K., Osborne T.F., Chin D.J., Gil G., Brown M.S., Goldstein J.L., and Luskey K.L. HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38 (1984) 275-285
30. Sato R., Goldstein J.L., and Brown M.S. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9261-9265
31. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFarlane P.W., McKillop J.H., and Packard C.J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N. Engl. J. Med. 333 (1995) 1301-1307
32. Sirtori C.R., and Galli C. N-3 fatty acids and diabetes. Biomed. Pharmacother. 56 (2002) 397-406
33. Slade J.M., Delano M.C., and Meyer R.A. Elevated skeletal muscle phosphodiesters in adults using statin medications. Muscle Nerve 34 (2006) 782-784
34. Stadtman E.R. Protein oxidation and aging. Free Radic. Res. 40 (2006) 1250-1258
35. Stocks N., Allan J., and Mansfield P.R. Management of hyperlipidaemia. Aust. Fam. Physician 34 (2005) 447-453
36. Yang H., and Kenny A. The role of fish oil in hypertension. Conn. Med. 71 (2007) 533-538